Differential inhibition of human cytochrome P450 enzymes by ε-viniferin, the dimer of resveratrol: comparison with resveratrol and polyphenols from alcoholized beverages

This publication has 28 references indexed in Scilit:

• Inhibition of CYP3A-mediated oxidation in human hepatic microsomes by the dietary derived complex phenol, gallic acid
  Journal of Pharmacy and Pharmacology, 2002
• Trans-resveratrol modulates the catalytic activity and mRNA expression of the procarcinogen-activating human cytochrome P450 1B1
  Canadian Journal of Physiology and Pharmacology, 2000
• Resveratrol Is a Selective Human Cytochrome P450 1A1 Inhibitor
  Biochemical and Biophysical Research Communications, 1999
• Comparative study of radical scavenger and antioxidant properties of phenolic compounds from Vitis vinifera cell cultures using in vitro tests
  Life Sciences, 1997
• Cancer Chemopreventive Activity of Resveratrol, a Natural Product Derived from Grapes
  Science, 1997
• Non-specific inhibition of cytochrome P450 activities by chlorophyllin in human and rat liver microsomes
  Carcinogenesis: Integrative Cancer Research, 1995
• Powerful hepatoprotective and hepatotoxic plant oligostilbenes, isolated from the Oriental medicinal plantVitis coignetiae (Vitaceae)
  Cellular and Molecular Life Sciences, 1995
• Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes.
  Environmental Health Perspectives, 1994
• Inhibition of human LDL oxidation by resveratrol
  The Lancet, 1993
• Disease resistance of Vitis spp. and the production of the stress metabolites resveratrol, ε-viniferin, α-viniferin and pterostilbene
  Physiological Plant Pathology, 1981